These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 15947554

  • 1. Bilirubin response to corticosteroids in severe alcoholic hepatitis.
    Morris JM, Forrest EH.
    Eur J Gastroenterol Hepatol; 2005 Jul; 17(7):759-62. PubMed ID: 15947554
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial.
    Cho Y, Park YS, Kim HY, Kim W, Lee HJ, Kim DJ.
    Trials; 2018 Dec 22; 19(1):696. PubMed ID: 30577864
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pentoxifylline vs. corticosteroid to treat severe alcoholic hepatitis: a randomised, non-inferiority, open trial.
    Park SH, Kim DJ, Kim YS, Yim HJ, Tak WY, Lee HJ, Sohn JH, Yoon KT, Kim IH, Kim HS, Um SH, Baik SK, Lee JS, Suk KT, Kim SG, Suh SJ, Park SY, Kim TY, Jang JY, Korean Association for the Study of the Liver (KASL)-Alcohol Related Problems Study Group.
    J Hepatol; 2014 Oct 22; 61(4):792-8. PubMed ID: 24845609
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prednisolone plus S-adenosil-L-methionine in severe alcoholic hepatitis.
    Tkachenko P, Maevskaya M, Pavlov A, Komkova I, Pavlov C, Ivashkin V.
    Hepatol Int; 2016 Nov 22; 10(6):983-987. PubMed ID: 27337960
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro steroid resistance correlates with outcome in severe alcoholic hepatitis.
    di Mambro AJ, Parker R, McCune A, Gordon F, Dayan CM, Collins P.
    Hepatology; 2011 Apr 22; 53(4):1316-22. PubMed ID: 21400552
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A prognostic evaluation and management of alcoholic hepatitis.
    Rana R, Wang SL, Li J, Xia L, Song MY, Yang CQ.
    Minerva Med; 2017 Dec 22; 108(6):554-567. PubMed ID: 28602070
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials.
    Louvet A, Thursz MR, Kim DJ, Labreuche J, Atkinson SR, Sidhu SS, O'Grady JG, Akriviadis E, Sinakos E, Carithers RL, Ramond MJ, Maddrey WC, Morgan TR, Duhamel A, Mathurin P.
    Gastroenterology; 2018 Aug 22; 155(2):458-468.e8. PubMed ID: 29738698
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alcoholic hepatitis: Towards an era of personalised management.
    Degré D, Wandji LCN, Moreno C, Louvet A.
    United European Gastroenterol J; 2020 Nov 22; 8(9):995-1002. PubMed ID: 32718222
    [Abstract] [Full Text] [Related]

  • 20. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.
    Mathurin P, Mendenhall CL, Carithers RL, Ramond MJ, Maddrey WC, Garstide P, Rueff B, Naveau S, Chaput JC, Poynard T.
    J Hepatol; 2002 Apr 22; 36(4):480-7. PubMed ID: 11943418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.